Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (201-210 of 300) with videos related to

Pageof 30
Sort By:
Neoplasia (New York, N.Y.)|January 12, 2013
Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma modelMiriam Benezra, Dolores Hambardzumyan, Oula Penate-Medina, et al.
The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell LymphomaHeiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Nuclear Medicine Communications|February 28, 2012
Computer-aided quantitative bone scan assessment of prostate cancer treatment responseMatthew S Brown, Gregory H Chu, Hyun J Kim, et al.
The Journal of Clinical Investigation|August 25, 2007
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptorJaspreet Singh Jaggi, Jorge A Carrasquillo, Surya V Seshan, et al.
Science Translational Medicine|October 31, 2014
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probeEvan Phillips, Oula Penate-Medina, Pat B Zanzonico, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
Measurement of lung tumor motion using respiration-correlated CTGig S Mageras, Alex Pevsner, Ellen D Yorke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2004
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancerSteven M Larson, Michael Morris, Ilonka Gunther, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-LintuzumabTodd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I studyJason A Konner, Katherine M Bell-McGuinn, Paul Sabbatini, et al.
Pageof 30

Showing results (201-210 of 300) with videos related to

Sort By:
Pageof 30
Neoplasia (New York, N.Y.)|January 12, 2013
Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma modelMiriam Benezra, Dolores Hambardzumyan, Oula Penate-Medina, et al.
The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell LymphomaHeiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Nuclear Medicine Communications|February 28, 2012
Computer-aided quantitative bone scan assessment of prostate cancer treatment responseMatthew S Brown, Gregory H Chu, Hyun J Kim, et al.
The Journal of Clinical Investigation|August 25, 2007
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptorJaspreet Singh Jaggi, Jorge A Carrasquillo, Surya V Seshan, et al.
Science Translational Medicine|October 31, 2014
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probeEvan Phillips, Oula Penate-Medina, Pat B Zanzonico, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
Measurement of lung tumor motion using respiration-correlated CTGig S Mageras, Alex Pevsner, Ellen D Yorke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2004
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancerSteven M Larson, Michael Morris, Ilonka Gunther, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-LintuzumabTodd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I studyJason A Konner, Katherine M Bell-McGuinn, Paul Sabbatini, et al.
Pageof 30